OTO-104 for the Treatment of Meniere's Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Meniere's Disease

In brief

The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.

Key facts

Study ID
NCT01412177
Run by
Otonomy, Inc.
People needed
154
Starts
2013-11-01
Expected to finish
2015-04-01
Last updated by the study team
2015-09-03

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.